Reference62 articles.
1. Badruddoja MA, Penne K, Desjardins A et al (2007) Phase II study of cloretazine for the treatment of adults with recurrent glioblastoma multiforme. Neuro Oncol 9:70–74
2. Ballman KV, Buckner JC, Brown PD et al (2006) The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme. Neuro Oncol 9:29–38
3. Bao S, Wu Q, Sathornsumetee S et al (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66:7843–7848
4. Belanich M, Pastor M, Randall T et al (1996) Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res 56:783–788
5. Brada M, Hoang-Xuan K, Ramplin R et al (2001) Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 12:149–150
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献